{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:27:29Z","timestamp":1791070049451,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1954,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/ki.2010.132","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T12:43:02Z","timestamp":1273063382000},"page":"279-286","source":"Crossref","is-referenced-by-count":98,"title":["Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice"],"prefix":"10.1016","volume":"78","author":[{"given":"Fadi","family":"Fakhouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Goicoechea","family":"de Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Brune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.132_bb0010","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2007030356","article-title":"New approaches to the treatment of dense deposit disease","volume":"18","author":"Smith","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.132_bb0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals","volume":"151","author":"Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/ki.2010.132_bb0020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1042\/bst0150648","article-title":"A familial deficiency of complement factor H","volume":"15","author":"Lopez-Larrea","year":"1987","journal-title":"Biochem Soc Trans"},{"key":"10.1038\/ki.2010.132_bb0025","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.132_bb0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2010.132_bb0035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000167525","article-title":"Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3","volume":"7","author":"Linshaw","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2010.132_bb0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.1983.89","article-title":"An inherited defect in the C3 convertase, C3b, Bb, associated with glomerulonephritis","volume":"23","author":"Marder","year":"1983","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.132_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.116.1.1","article-title":"C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase","volume":"116","author":"Daha","year":"1976","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.132_bb0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.164.3878.436","article-title":"Serum C\u20193 lytic system in patients with glomerulonephritis","volume":"164","author":"Spitzer","year":"1969","journal-title":"Science"},{"key":"10.1038\/ki.2010.132_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"10.1038\/ki.2010.132_bb0060","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.0601094103","article-title":"Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice","volume":"103","author":"Pickering","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2010.132_bb0065","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice","volume":"118","author":"Rose","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.132_bb0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/vr.140.15.392","article-title":"Eradication of porcine factor H deficiency in Norway","volume":"140","author":"Hogasen","year":"1997","journal-title":"Vet Rec"},{"key":"10.1038\/ki.2010.132_bb0075","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI117751","article-title":"Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency","volume":"95","author":"Hogasen","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.132_bb0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/vr.137.10.240","article-title":"Porcine membranoproliferative glomerulonephritis type II: an autosomal recessive deficiency of factor H","volume":"137","author":"Jansen","year":"1995","journal-title":"Vet Rec"},{"key":"10.1038\/ki.2010.132_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1523-1755.1998.00765.x","article-title":"In situ complement activation in porcine membranoproliferative glomerulonephritis type II","volume":"53","author":"Jansen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.132_bb0090","first-page":"1356","article-title":"Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease)","volume":"143","author":"Jansen","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.132_bb0095","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative glomerulonephritis type II (dense deposit disease): an update","volume":"16","author":"Appel","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.132_bb0100","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.molimm.2009.03.030","article-title":"Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase","volume":"46","author":"Paixao-Cavalcante","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1038\/ki.2010.132_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.132_bb0110","first-page":"179","article-title":"Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis","volume":"142","author":"Schulze","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2010.132_bb0115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1681\/ASN.2006101125","article-title":"Mouse podocyte complement factor H: the functional analog to human complement receptor 1","volume":"18","author":"Alexander","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.132_bb0120","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ki.2008.354","article-title":"C3 deposition glomerulopathy due to a functional factor H defect","volume":"75","author":"Habbig","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.132_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.132_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Clinical Practice Guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom","volume":"148","author":"Taylor","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1038\/ki.2010.132_bb0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s00467-007-0438-x","article-title":"Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate","volume":"22","author":"Cho","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2010.132_bb0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2004.10.018","article-title":"Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15","volume":"45","author":"Licht","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.132_rf0145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s004670100609","article-title":"Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency","volume":"16","author":"Nathanson","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2010.132_bb0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2007.11.032","article-title":"Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits","volume":"51","author":"Boyer","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2010.132_bb0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mpd.2001.112649","article-title":"Familial hemolytic uremic syndrome associated with complement factor H deficiency","volume":"138","author":"Landau","year":"2001","journal-title":"J Pediatr"},{"key":"10.1038\/ki.2010.132_bb0160","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s004670050515","article-title":"Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H","volume":"12","author":"Ohali","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2010.132_bb0165","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00467-006-0237-9","article-title":"Secondary failure of plasma therapy in factor H deficiency","volume":"21","author":"Nathanson","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2010.132_bb0170","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2353\/ajpath.2009.090183","article-title":"Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"175","author":"Leung","year":"2009","journal-title":"Am J Pathol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815545316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815545316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:35:51Z","timestamp":1685583351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815545316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0085253815545316"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.132","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}